title: Spinal cord tumors in children: long-term results of combined surgical and radiation treatment.
abstract: The authors report a series of 31 children under 17 years of age with primary spinal cord tumors who underwent radiation treatment following decompression laminectomy with or without tumor resection between 1959 and 1990. The tumors consisted of 15 astrocytomas, 11 ependymomas, one mixed glioma, one gangliolioma, and three of unknown histology. Ten- and 20-year survival rates and 10- and 20-year relapse-free survival rates for the 28 patients with known histology were 80% and 53%, and 73% and 67%, respectively. Eleven patients (35%) had no resection, 14 (45%) had a partial resection, and six (19%) had a grossly complete resection. Eight patients (26%) are dead: five due to recurrent tumor, two due to a second malignant tumor, and one due to intercurrent disease. primary tumor relapse or progression occurred in nine patients (29%), four of whom were salvaged. A second malignant tumor developed in four patients (13%), two of whom died. Local control of the tumor was finally achieved in 26 cases (84%), despite either grossly incomplete or no resection in 25 of these cases (81%). These statistics suggest that radiation treatment without resection may achieve long-term control in children with astrocytoma or ependymoma of the spinal cord.
authors.affiliation: Division of Radiation Oncology, Toronto-Bayview Regional Cancer Centre, Sunnybrook Health Science Centre, Ontario, Canada.
authors.forename: C
authors.initials: C
authors.lastname: O'Sullivan
authors.forename: R D
authors.initials: RD
authors.lastname: Jenkin
authors.forename: M A
authors.initials: MA
authors.lastname: Doherty
authors.forename: H J
authors.initials: HJ
authors.lastname: Hoffman
authors.forename: M L
authors.initials: ML
authors.lastname: Greenberg
mesh_terms: D000293:Adolescent; D001254:Astrocytoma / Q000401:mortality / Q000628:therapy; D001932:Brain Neoplasms / Q000556:secondary; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004806:Ependymoma / Q000401:mortality / Q000556:secondary / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D005910:Glioma / Q000150:complications / Q000401:mortality / Q000628:therapy*; D006801:Humans; D007738:Kyphosis / Q000209:etiology; D007796:Laminectomy; D008297:Male; D009364:Neoplasm Recurrence, Local; D016609:Neoplasms, Second Primary; D010264:Paraplegia / Q000209:etiology; D018714:Radiotherapy, Adjuvant; D013120:Spinal Cord Neoplasms / Q000150:complications / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate; D016896:Treatment Outcome; D001750:Urinary Bladder, Neurogenic / Q000209:etiology